FDA authorizes Quest Diagnostics COVID-19 nasal specimen self-collection kit for emergency use
Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels
Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels
The RNAdvance Viral XP is a RNA extraction kit validated for use in infectious disease and real-time PCR virus research
Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers' specific analytical requirements
The CXT 353 is designed to minimize aerosol exposure to viral samples like COVID-19
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
Harnessing the most powerful force in the fight against disease — natural human immunity
The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford
First patients are expected to be enrolled shortly and additional European regulatory approvals are in process
The result represents an essential step towards using these molecules for fundamental physics research and beyond
The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights
People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus
Microsemi CRP hematology analyzers have been installed during COVID-19 ‘lockdown’ in POC locations to help reduce hospital admissions
Discover how clinicians at the Center for Personalized Medicine identify and track different coronavirus strains
Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Join this expert webinar on Wednesday, June 10, to learn how to improve throughput and result quality in PCR and qPCR workflows
Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials
The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour
COVID-19 molecular diagnostic and serology antibody testing at core of new suite of services
Ms. Knauer received a certificate signed by the German Federal Minister of Economics and Energy Peter Altmaier
The CE-IVD marked system will enable diagnostic pathologists with new applications